We retrospectively reviewed the postoperative hemorrhagic risk in patients undergoing surgery for coronary revascularization who had received platelet antiaggregants preoperatively. A significant increase in postoperative hemorrhage and a higher percentage of reoperations for this reason was observed in the patients treated with ticlopidine. However, there were no major differences in the platelet counts among the groups compared.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/106002808501900912 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!